» Articles » PMID: 33777370

Membranous Nephropathy Associated with Viral Infection

Overview
Journal Clin Kidney J
Specialty Nephrology
Date 2021 Mar 29
PMID 33777370
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Membranous nephropathy (MN) can be associated with hepatitis infection and less commonly with human immunodeficiency virus (HIV) infection. The significance of anti-phospholipase A2 receptor (PLA2R) and anti-thrombospondin type 1 domain-containing 7A (THSD7A) antibodies in this setting is unclear.

Methods: We describe the clinical, histopathological and outcome data of 19 patients with MN and hepatitis B virus (HBV), hepatitis C virus (HCV) or HIV infection identified through our renal biopsy database and the association with anti-PLA2R antibodies and anti-THSD7A antibodies.

Results: The cohort consisted of 19 patients, 8 male and 11 female, with a median age of 42 years (range 23-74). HBV infection was found in six cases, HCV in four and HIV in nine (two HIV patients had HBV co-infection and one HCV co-infection). PLA2R staining on biopsy was positive in 10/19 patients: 4 with HBV-MN, 3 with HCV-MN and 3 with HIV-MN and circulating anti-PLA2R antibodies were detected in 7/10 cases. THSD7A staining on biopsy was positive in three PLA2R-negative cases, one with HBV-MN and two with HIV-MN. Mean proteinuria was higher in the PLA2R-positive group and the median urinary protein:creatinine ratio (uPCR) was 963 mg/mmol (range 22-2406) compared with the PLA2R-negative group [median uPCR 548 mg/mmol (range 65-1898); P = 0.18 Mann-Whitney]. Spontaneous remission occurred in 6/19 patients and after-treatment remission occurred in 7/11 patients. Renal function was preserved in all but two patients who required haemodialysis 2 and 11 years from diagnosis.

Conclusions: We describe a cohort of patients with MN associated with viral infection, including rare cases of HIV-MN with PLA2R and THSD7A positivity. The mechanism of coincidental or viral-related MN needs to be investigated further.

Citing Articles

Targeting hepatitis B virus-associated nephropathy: efficacy and challenges of current antiviral treatments.

Hu Y, Zhang Y, Jiang W Clin Exp Med. 2025; 25(1):57.

PMID: 39954162 PMC: 11829913. DOI: 10.1007/s10238-025-01584-4.


Viral Infection Associated Membranous Nephropathy: Clinical Presentation and Outcomes.

Kaur P, Prabhahar A, Niranjan A, Kumar V, Pal D, Rathi M Indian J Nephrol. 2025; 35(1):70-76.

PMID: 39872252 PMC: 11763019. DOI: 10.25259/IJN_57_2024.


An Updated Review of Membranous Nephropathy.

Efe O, So P, Anandh U, Lerma E, Wiegley N Indian J Nephrol. 2024; 34(2):105-118.

PMID: 38681023 PMC: 11044666. DOI: 10.25259/ijn_317_23.


Target Antigens of Membranous Nephropathy With Syphilis Infection.

Zhang L, Zhang M, Xie Q, Wang Y, Ni Z, Liu S Kidney Int Rep. 2024; 9(2):401-409.

PMID: 38344711 PMC: 10851000. DOI: 10.1016/j.ekir.2023.11.021.


HIV-Associated Nephropathy in 2022.

Rivera F, Ansay M, Golbin J, Alfonso P, Mangubat G, Menghrajani R Glomerular Dis. 2023; 3(1):1-11.

PMID: 36816427 PMC: 9936764. DOI: 10.1159/000526868.


References
1.
Bhimma R, Coovadia H . Hepatitis B virus-associated nephropathy. Am J Nephrol. 2004; 24(2):198-211. DOI: 10.1159/000077065. View

2.
Qin W, Beck Jr L, Zeng C, Chen Z, Li S, Zuo K . Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011; 22(6):1137-43. PMC: 3103733. DOI: 10.1681/ASN.2010090967. View

3.
Szczech L, Gupta S, Habash R, Guasch A, Kalayjian R, Appel R . The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004; 66(3):1145-52. DOI: 10.1111/j.1523-1755.2004.00865.x. View

4.
Ponticelli C, Glassock R . Glomerular diseases: membranous nephropathy--a modern view. Clin J Am Soc Nephrol. 2013; 9(3):609-16. PMC: 3944756. DOI: 10.2215/CJN.04160413. View

5.
Wilson L, Widman D, Dikman S, Gorevic P . Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin Arthritis Rheum. 2003; 32(3):163-73. DOI: 10.1053/sarh.2002.37277. View